The global renal biomarkers market size valued USD 1042.1 billion by 2020 and expected to reach USD 1454.08 billion by 2027, at a CAGR of 6.8% during the forecast period 2021-2027. Renal diseases are one of the major cause of death in geriatric population. Renal biomarkers are measurable indicators used to screening, monitoring, and diagnosing the activity of renal diseases by determining their blood and urine levels. The biomarkers are administered into kidneys to determine the renal functions. The early diagnosis of renal diseases helps to take proper treatment before the irreversible damage of kidneys.